Tetrahydrobiopterin Concentrations in Normal and Coronary Artery Diseased Heart Tissue
Open Access
- 6 May 2016
- journal article
- Published by Peertechz Publications Private Limited in Journal of Cardiovascular Medicine and Cardiology
- Vol. 3 (1), 014-017
- https://doi.org/10.17352/2455-2976.000023
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recyclingFree Radical Biology & Medicine, 2013
- Myocardial protection by co-administration of l-arginine and tetrahydrobiopterin during ischemia and reperfusionInternational Journal of Cardiology, 2013
- Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failureJournal of Molecular and Cellular Cardiology, 2011
- Incomplete Recovery of Myocyte Contractile Function Despite Improvement of Myocardial Architecture With Left Ventricular Assist Device SupportCirculation: Heart Failure, 2011
- Tetrahydrobiopterin, superoxide, and vascular dysfunctionFree Radical Biology & Medicine, 2009
- Vascular protection by tetrahydrobiopterin: progress and therapeutic prospectsTrends in Pharmacological Sciences, 2009
- Myocardial ischemia results in tetrahydrobiopterin (BH 4 ) oxidation with impaired endothelial function ameliorated by BH 4Proceedings of the National Academy of Sciences of the United States of America, 2007
- Global Improvement of Vascular Function and Redox State With Low-Dose Folic AcidJournal of the American College of Cardiology, 2007
- Role of Myocardial Neuronal Nitric Oxide Synthase–Derived Nitric Oxide in β-Adrenergic Hyporesponsiveness After Myocardial Infarction–Induced Heart Failure in RatJournal of the American College of Cardiology, 2004
- Tetrahydrobiopterin and Dysfunction of Endothelial Nitric Oxide Synthase in Coronary ArteriesJournal of the American College of Cardiology, 1995